We always hear that DUT only lowers scalp DHT by 50% (fin at 40%) but a study within the hair follicle itself shows that DUT nukes DHT to near undetectable levels... so which is it??
    Finasteride/Dutasteride 9/10/2025

    From the encyclopedia
    Dutasteride →

    Heavy duty finasteride that comes with higher risks

    Finasteride →

    Frontline, gold standard treatment for combatting androgenic alopecia

    At a glance
    In this educational post, the primary subjects mentioned are the tone is 😐 neutral.

    Other terms

    Dutasteride significantly reduces DHT levels in hair follicles, potentially more effectively than previously thought. The discussion highlights differences in DHT measurements and the impact on hair loss treatment.
    View this post in the Community →

    Similar Community Posts Join

    6 / 6 results

    Related Research

    6 / 6 results
      Updates in Treatment for Androgenetic Alopecia

      research Updates in Treatment for Androgenetic Alopecia

      January 2025 in “Annals of Dermatology”
      This review discusses current and emerging treatments for androgenetic alopecia, covering mechanisms, efficacy, and safety of both androgen-targeted and non-androgen-targeted approaches, but reports no new clinical results.
      Systemic Treatment Options for Androgenic Alopecia

      research Systemic treatment options for androgenic alopecia

      March 2026 in “Lithuanian University of Health Sciences”
      In this study, a systematic review found that for androgenetic alopecia, systemic treatments like finasteride, dutasteride, and oral minoxidil are effective at slowing progression and promoting hair regrowth, with additional antiandrogen therapy options for women.
      Androgenetic Alopecia: A Review and Emerging Treatments

      research Androgenetic Alopecia: a Review and Emerging Treatments

      1 citations , July 2017 in “Clinical research in dermatology”
      This review covers the pathogenesis, diagnosis, and potential new treatments for androgenetic alopecia but reports no new clinical findings, highlighting an ongoing need for effective therapies.
      Androgenetic Alopecia: An Update

      research Androgenetic alopecia: An update

      July 2023 in “JAAD International”
      This study describes androgenetic alopecia as a common non-scarring hair loss condition primarily influenced by genetic factors and androgen sensitivity, notably impacting psychosocial well-being, especially in females and younger males seeking treatment.